Background: We have previously shown that maternal cow's milk (CM) elimination
diseases such as allergies. We have previously shown that high levels of BM total and specific IgA are associated with protection against cow's milk allergy (CMA), 3 which is typically the first sign of breach in development of oral tolerance. Understanding the origins and the specificity of BM IgA may provide guidance on ways to enhance the protective properties of BM.
IgA in serum is mainly monomeric (mIgA), whereas in mucosal fluid, polymeric IgA is predominant. Mucosal IgA antibodies are produced by plasma cells in the lamina propria and are transported across epithelial cells by the polymeric immunoglobulin receptor (pIgR). 4 At apical site, IgA is released as two mIgA molecules linked by the J chain peptide and the extracellular ligand binding portion of pIgR, called the secretory component. BM is a rich source of secretory IgA (SIgA) with lesser amounts of SIgG and SIgM. 5 Milk IgA is produced by mammary gland B cells that have migrated from the mother's intestine via the "entero-mammary link" 6, 7 This is suggested by animal studies, in which B cells from Peyer's patches and mesenteric lymph nodes were shown to migrate specifically to the lactating mammary gland. [8] [9] [10] [11] This is controlled by hormones antepartum, 12 and by the mucosal vascular addressin MadCAM-1, which interacts with the gut homing receptor a 4 b 7 integrin 13 and mucosa-associated CCL28/CCR10 link. 14 Consistent with this, in a rabbit model oral and inhaled RSV resulted in RSV-IgA production in milk, bronchial and enteral secretions, whereas systemic immunization did not. 15 Studies in women in late pregnancy 16 showed an increase in plasma cells in milk, but not in saliva or serum, specific to the non-pathogenic E. coli strain used for oral immunization. Thereby the antibody specificity of BM reflects the antigenic stimulation encountered for example by the maternal gut. Antibodies in breast milk may also partly originate from the systemic compartment as suggested by high levels of dimeric IgA detected in breast milk after systemic passive immunization with broadly neutralizing HIV antibodies. 17 For foodspecific IgA, the presence of an entero-mammary link was suggested by our previous work, which showed that a strict maternal diet eliminating CM was associated with lower levels of CM-specific IgA in BM than a regular diet containing CM. 3 This implies that the food antigenic stimulation encountered by the maternal gut acutely directs the antibody specificity of BM, similar to what has been shown to be the case for IgA responses to microbes that are constantly modified to reflect the microbiota present in the gut lumen. 18 Pioneering work has suggested that IgA production is associated with oral tolerance 19 and transient IgA deficiency in infancy seen in serum and saliva has been documented in atopy. [20] [21] [22] [23] In CMA, low serum IgA levels to b-lactoglobulin at diagnosis have been shown to be associated with persistence of CMA. 24 Increases in serum-specific
IgA and IgA 2 have been associated with development of natural tolerance in egg allergy. 23 Antigen-specific serum IgA has been shown to increase in subcutaneous immunotherapy with aeroallergens, 25 in oral immunotherapy (OIT) to egg 26 and in successful CM OIT. 27 Simultaneously, CM allergen binding by serum IgA has been shown to increase over time in persisting CMA. 28 There is some evidence to suggest that IgA 2 may reflect changes in local environments as indicated by increases in TGF-b from nasal biopsies that correlate with serum IgA 2 levels and by salivary specific IgA that has been shown to be induced with peanut sublingual immunotherapy. 29 Interestingly, serum IgA may play a role in preventing food-induced reactions, as seen in mouse models of egg allergy, 30 and in vitro experiments of IgE blocking activity. 31 In light of the relative delay in maturation of the total IgA levels in early childhood, and the possible importance of serum IgA in infants prone to developing food allergy, we were interested in how infants' epitope-specific IgA develops in early infancy. We also investigated whether food-specific IgA epitope profiles differ intra-individually between mother's serum and BM, which would suggest converted to a Z-score as previously described. 33 Briefly, a Z-score is defined as IgA binding measured in relation to background binding:
| Samples
(sample intensity -median blank intensity) divided by median absolute deviation of blank intensity. In addition to individual peptides' Z-scores, total Z-score for a protein is expressed as a sum of all pep- Table S1 ). On the contrary, epitope 2 on b-lactoglobulin was predominantly recognized by serum samples, and only by a small number of BM samples (2/6/1 positive in milk only/serum only/both).
| IgA specificity is distinct between paired samples of mother's milk and serum and infant's serum
Because the same epitopes were generally immunogenic between BM and sera in the whole cohort, we were next interested in comparing epitope recognition patterns within a mother-infant pair. When IgA peptide binding profiles were compared between mother's milk and serum, it was noted that there was significant discordance. Although some epitopes were recognized by IgA antibodies in the same individual's milk and serum samples, many were bound by BM IgA or by mother's serum IgA but not by both ( Figure 2 , Table S1 ). The percentage of mothers with both milk and serum IgA recognizing the same epitope varied depending on the protein, ranging from 13% in a s1 -casein to 73% in j-casein (Table 3 ). The most immunogenic epitopes in a s1 -, b-and j-casein, epitopes 8, 10, 15 and 18 were recognized by IgA in Table S1 ), whereas most epitopes were recognized by BM or serum IgA, but not both (j<0.2).
IgA-binding epitopes in mothers' and infants' sera were also discordant ( Fig. S1B) as were epitopes between breast milk and infant serum (Fig. S1C) . Only a minority of epitopes were recognized by both infant's and mother's sera within the dyad.
| Infants who develop CMA have mothers with elevated serum CM-specific IgA binding
In the next step, we sought to assess the impact of the infant's age on the production of CM allergen-specific IgA in all three sample types (Figure 3 ). We noted that in infant sera, IgA reactivity was present even in the earliest (1 month 
| DISCUSSION
In the present study, we have shown that epitope specificity of BM IgA significantly differed from that of the paired maternal serum for each assessed CM allergen. This suggests that distinct pools of foodspecific IgA ASCs home to mucosal and systemic immune systems. It is possible that these mammary gland ASCs represent B cells that originate in the gut, similar to what has been described for the entero-mammary link of pathogen-specific IgA ASCs. 13 This could be further assessed by comparing IgA epitope specificity in BM to that of the salivary IgA from the sublingual compartment, which has recently been suggested as a novel non-invasive proxy for intestinal immune induction. 36 Alternatively, this could result from distinct epitopes being presented to mucosal and systemic T and B cells. We also found that epitope-specific IgA was detectable in infants' sera as early as 3 months of age. Lastly, sera of mothers with a CMA infant had increased binding of epitope-specific IgA to CM proteins compared to those with a non-CMA infant.
In serum, there is a relative delay in the development of total
IgA seen until about 2 years of life, and there is a dramatic increase in the number of peripheral blood CD27+IgA+ memory B cells, consistent with T cell-dependent development within the first 18 months of life. 37 In the current study, we showed that epitopespecific IgA was detectable in infants' sera starting at a relatively young age of less than 3 months. Plasma cells producing IgA are only generated after birth to provide SIgA to the lumen, and therefore, infants' mucosal IgA production is considered compromised at least for the first month of life. [38] [39] [40] Normally, Peyer's patch, mesenteric lymph node and mucosal lamina propria B cells convert IgM to
IgA via class switch recombination (CSR). 41 Two pathways for pro- factors. 38 Therefore, delayed TI responses may contribute to the delayed induction of intestinal IgA during early infancy. Given breast milk IgA does not cross the infant gut barrier, the early serum-specific IgA production reflects the infant's own mucosal production of
IgA to antigens such as cow's milk, which are among the first foreign proteins introduced to the infant gut. We did not have samples to assess the development of mucosal IgA, nor did we have samples prior to 1 month of age to assess when epitope-specific IgA responses were initially seen.
Interestingly, we also show that mothers of CMA infants had significantly increased binding of serum IgA, but not breast milk IgA specific to CM epitopes, compared to mothers with a non-CMA infant. However, utilizing conventional ELISA, we and others have shown that milk from mothers of CMA infants have lower levels of total and CM-specific IgA than those with healthy infants. The significant difference between these methods is that ELISA detects both sequential and conformational epitopes, 32, 42 whereas the current method detects sequential epitopes only. In our previous study, we found that maternal diets eliminating CM are associated with lower specific IgA levels in BM. 3 In the light of the findings of the current study, another possibility is that the low BM IgA production is due to an inability to produce mucosal IgA antibodies, with simultaneous upregulation of systemic antibody responses. Although the mothers in the present study were tolerating CM, their systemic IgA responses were increased similarly to what has been reported in persistent CMA. 28 Because avoidance of CM was seen in most mothers with CMA infants, the present study was too small in number to dissect out at the epitope level whether low BM IgA in mothers with a CMA infant is due to an inability to produce mucosal IgA or due to lack of stimulation by CM exposure. Nevertheless, strategies to increase production of mucosal (breast milk) IgA production may aid in prevention of food allergies.
Other limitations of the study include limited amounts of infant serum available to examine production of other immunoglobulin classes, including IgA 1 vs predominantly mucosally derived IgA 2 , as well as systemically prevalent IgG, which would have been of interest. Furthermore, we investigated IgA binding only to linear, not conformational epitopes, which certainly play a major role in CMA. 43 The strengths include the access to paired mother-infant samples at a young age, prior to the development of established CMA.
The function of BM IgA antibodies is not completely understood. 44, 45 By reinforcing the epithelial barrier, SIgA inhibits inappropriate immune activation by microorganisms and antigens in the lumen of the intestinal and respiratory tracts. 46 This immune exclusion could mediate tolerance by providing protection against excessive and uncontrolled antigen influx. Our previous data using cell culture transcytosis assays support the view that BM plays a role in immune exclusion preventing excess antigen uptake in enterocytes. 3 Alternatively, BM antibodies could favour focused antigen uptake, for example via M cells as immune complexes, which could target the antigen for presentation favouring tolerance development. This is suggested by studies of Rey and Corthesy 47 who showed that
SIgA was targeted to Peyer's patch dendritic and T cells after transport by intestinal M cells, via a so-far unknown IgA receptor as described by Mantis. 48 This possibility is supported by our findings of facilitated peanut uptake to Peyer's patches in the presence of peanut-specific antibodies in mice. 49 Lastly, it is known that BM antibodies play a role in gut homeostasis by shaping the gut microbiota. 50 In summary, we show that the mammary gland IgA antibody repertoire to CM proteins is distinct from the systemic immune compartment, which may be due to specific homing of mucosa- 
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